RECOGNITION OF MULTIPLE EFFECTS OF ETHAMBUTOL ON METABOLISM OF MYCOBACTERIAL CELL-ENVELOPE

被引:124
作者
DENG, LY [1 ]
MIKUSOVA, K [1 ]
ROBUCK, KG [1 ]
SCHERMAN, M [1 ]
BRENNAN, PJ [1 ]
MCNEIL, MR [1 ]
机构
[1] COLORADO STATE UNIV, DEPT MICROBIOL, FT COLLINS, CO 80523 USA
关键词
D O I
10.1128/AAC.39.3.694
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Ethambutol is known to rapidly inhibit biosynthesis of the arabinan component of the mycobacterial cell wall core polymer, arabinogalactan (K. Takayama and J. O. Kilburn, Antimicrob. Agents Chemother. 33:1493-1499, 1989), This effect was confirmed, and it was also shown that ethambutol inhibits biosynthesis of the arabinan of lipoarabinomannan, a lipopolysaccharide noncovalently associated with the cell wall core, In contrast to cell wall core arabinan, which is completely inhibited by ethambutol, synthesis of the arabinan of lipoarabinomannan was only partially affected, demonstrating a differential effect on arabinan synthesis in the two locales, Further studies of the effect of ethambutol on cell wall biosynthesis revealed that the synthesis of galactan in the cell wall core is strongly inhibited by the drug, In addition, ethambutol treatment resulted in the cleavage of arabinosyl residues present in the mycobacterial cell wall; more than 50% of the arabinan in the cell wall core was removed from the wall 1 h after addition of the drug to growing mycobacterial cultures, In contrast, galactan,vas not released from the cell wall during ethambutol treatment, The natural function of the arabinosyl-releasing enzyme remains unknown, but its action in combination with inhibition of synthesis during ethambutol treatment results in severe disruption of the mycobacterial cell wall, Accordingly, ethambutol-induced damage to the cell wall provides a ready molecular explanation for the known synergetic effects of ethambutol with other chemotherapeutic agents, Nevertheless, the initial direct effect of ethambutol remains to be elucidated.
引用
收藏
页码:694 / 701
页数:8
相关论文
共 37 条
[1]   CHIRAL HPLC-CD STUDIES OF THE ANTITUBERCULOSIS DRUG (+)-ETHAMBUTOL [J].
BLESSINGTON, B ;
BEIRAGHI, A ;
LO, TW ;
DRAKE, A ;
JONAS, G .
CHIRALITY, 1992, 4 (04) :227-229
[2]   STUDY OF THE STEREOCHEMISTRY OF ETHAMBUTOL USING CHIRAL LIQUID-CHROMATOGRAPHY AND SYNTHESIS [J].
BLESSINGTON, B ;
BEIRAGHI, A .
JOURNAL OF CHROMATOGRAPHY, 1990, 522 :195-203
[3]   THIN-LAYER CHROMATOGRAPHY OF LIPID ANTIGENS AS A MEANS OF IDENTIFYING NONTUBERCULOUS MYCOBACTERIA [J].
BRENNAN, PJ ;
HEIFETS, M ;
ULLOM, BP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1982, 15 (03) :447-455
[4]  
CHATTERJEE D, 1992, J BIOL CHEM, V267, P6234
[5]  
CHATTERJEE D, 1991, J BIOL CHEM, V266, P9652
[6]  
CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228
[7]  
DAFFE M, 1990, J BIOL CHEM, V265, P6734
[8]   COLORIMETRIC METHOD FOR DETERMINATION OF SUGARS AND RELATED SUBSTANCES [J].
DUBOIS, M ;
GILLES, KA ;
HAMILTON, JK ;
REBERS, PA ;
SMITH, F .
ANALYTICAL CHEMISTRY, 1956, 28 (03) :350-356
[9]   EFFECT OF ETHAMBUTOL ON NUCLEIC ACID METABOLISM IN MYCOBACTERIUM SMEGMATIS AND ITS REVERSAL BY POLYAMINES AND DIVALENT CATIONS [J].
FORBES, M ;
KUCK, NA ;
PEETS, EA .
JOURNAL OF BACTERIOLOGY, 1965, 89 (05) :1299-&
[10]  
GAUGLER RW, 1973, J BIOL CHEM, V248, P6041